baber/WOPTO huggingface dataset:
Patent NZ-530798-A (NZ)
Title: Method for monitoring, control and/or regulation of a centrifuge for the centrifugal production of a milk product
Inventor: ZETTIER KARL-HEINZ
IPC: A01J11/10
Filed: 2002-07-02
Abstract: A Method of controlling and/or regulating for the centrifuge for the centrifugal production of a milk product, wherein: a) a skimmed milk sample is taken at an outlet (14) of the centrifuge from an out flowing liquid phase, b) a substance increasing the light transmittance is added to the skimmed milk sample c) the light transmittance of the skimmed milk sample is determined and the fat content is determined therefrom and d) as a function of the determination of the fat content , the setting of the centrifuge is controlled and/or regulated, e) the light transmittance of the skimmed milk sample is determined by transilluminating the skimmed milk sample by means of a light source (26) and measuring the light intensity by means of a photo cell (27) assigned to the skimmed milk sample.
Patent NZ-533299-A (NZ)
Title: Molecular conjugate comprising a human monoclonal antibody to a dendritic cell linked to either melanoma associated antigen or prostate associated antigen
Inventor: DEO YASHWANT M
IPC: G01N33/564
Filed: 2002-11-07
Abstract: Disclosed is a molecular conjugate comprising a human monoclonal antibody linked to a melanoma associated antigen, wherein the human monoclonal antibody binds to dendritic cells. Also disclosed are uses of said conjugate.
Patent NZ-536116-A (NZ)
Title: Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
Inventor: WATKINS CLARE J
IPC: C07D213/36
Filed: 2003-04-03
Abstract: Disclosed are compounds of formula (1) wherein: Cy is independently a cyclyl group; Q1 is independently a covalent bond or a cyclyl leader group; The piperazin-1,4-diyl group is optionally substituted; J1 is independently a covalent bond or -C(=O)-; J2 is independently -C(=O)- or -S(=O)2-; and Q2 is independently an acid leader group. Compounds of the type disclosed are histone deacetylase (HDAC) inhibitors and are useful in the treatment of conditions such as cancer, psoriasis and proliferative conditions.
Patent NZ-536143-A (NZ)
Title: Oxidation of alcohols using a solution containg an anhydride and a trialkanoyl periodinane compound
Inventor: CHIACCHIO UGO
IPC: C07C47/54
Filed: 2003-04-28
Abstract: Disclosed is a safe and effective method for selective oxidation of a primary or secondary alcohol to its corresponding aldehyde or ketone, consisting of reacting said alcohol with a solution containing an anhydride of the formula (RCO)2O and a trialkanoyl periodinane compound of formula (I) wherein R is C2-C4 alkyl.
Patent NZ-536763-A (NZ)
Title: Improvements in and relating to furniture and/or fastener mountings
Inventor: WOOTLIFF STANLEY JACK
IPC: A47C29/00
Filed: 2003-05-16
Abstract: The invention provides for a canopy for attachment to an item of furniture, the canopy including a first arm, the first arm being provided with a first component of a fastener system at or towards one end, the first arm being provided with a joint at or towards the other end, the joint being connected to a second arm, the joint allowing the orientation of the first arm to the second arm to be varied, the second arm being provided with a second joint, the second joint being connected to a further arm, one or more of the arms supporting one or more screens .
Patent NZ-537726-A (NZ)
Title: Methods of treating and preventing colitis involving IL-13 and NK-T cells
Inventor: STROBER WARREN
IPC: A61K45/00
Filed: 2002-06-14
Abstract: Disclosed is the use of an effective amount of an antibody that specifically binds an NK-T cell for the manufacture of a medicament for treating or preventing the inflammatory response of colitis. The antibody may decrease the number of NK-T cells, decrease NK-T cell activation or decrease the interaction between NK-T cells and their respective ligands. Also disclosed are methods for the screening of substances that treat or prevent the inflammatory response of colitis.
Patent NZ-540749-A (NZ)
Title: Animal carcass cutter with serrated and non-serrated cutting portions
Inventor: AIMERS RICHARD
Filed: 2005-06-15
Abstract: An animal carcass cutter having a) a body adapted to cut an animal carcass; b) an outer edge of the body having a non-serrated blade that forms at least part of the outer edge, which blade is a blade for cutting meat and soft tissue when the body and the carcass are brought in to contact; and c) an aperture extending from the outer edge into the interior of the body so that the aperture forms two substantially opposed internal edges, where each internal edge has at least one section that is a non-serrated blade for cutting meat and soft tissue, and has at least one section that is a serrated blade for cutting bone.
Patent NZ-542080-A (NZ)
Title: A device for detection of road surface condition using a light detection and range sensing apparatus
Inventor: FRIDTHJOF JACK
IPC: B60T8/172
Filed: 2004-03-15
Abstract: A device for detection of road surface properties or condition such as water, snow or ice is disclosed. The device reads surfaces by means of a detector mounted on individual vehicles and transmits the data from the vehicle with position data of the vehicle. This data can then be used by other road users for warning of road conditions ahead. The sensor device comprises a light source, a first detector to receive a portion of reflected light from the surface, a second detector for receiving a second portion of the reflected light, control means, and data processing means to detect the presence of snow, ice or water from the output of the detectors. The device also includes two polarisation filters, one in the path of the emitted light to the surface, and one in the path of the reflected light to at least one of the detectors.
Patent NZ-542171-A (NZ)
Title: Cyclic protein tyrosine kinase inhibitors
Inventor: LOMBARDO LOUIS J
IPC: A61P11/06
Filed: 2004-03-23
Abstract: Disclosed is the use of the cyclic compound of formula IV or a salt thereof in the preparation of a medicament for the oral treatment of cancer, wherein the cancer is chronic myelogenous leukemia (CML).
Patent NZ-549223-A (NZ)
Title: Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
Inventor: CHEN KEVIN X
IPC: C07D209/52
Filed: 2005-02-24
Abstract: Disclosed is a diol derivative compound of Formula I, or an enantiomer, stereoisomer, rotamer, tautomer, pharmaceutically acceptably salt, solvate, ester, or racemate thereof, wherein E is CH or CR, L is CH, CR, CH2CR, or CRCH2, A and M maybe be separate or joined substituents as described in the specification, Y is selected from a sulfur containing moiety as described in the specifaction, and wherein the other substituents are as defined in the specification. Also disclosed is the use of the compound treating HCV or a disorder associated with HCV.
Patent NZ-555054-A (NZ)
Title: Method and apparatus for adjusting respiratory mask sealing force
Inventor: BERTHON-JONES MICHAEL
IPC: A61M16/06
Filed: 2005-11-09
Abstract: A patient face interface (mask) for long period respiratory assistance is provided with an inflatable bladder to contact the face of the patient and which is pressurized to a pressure that exceeds the instantaneous pressure applied to the interior of the interface (for breathing by the patient) by a small positive amount so that the interface seals comfortably to the patient's face irrespective of the instantaneous pressure applied to the interior of the interface. The side wall of the bladder is thinner in the face contacting region 15 than in the regions b, c of the bladder that do not come in contact with the face of the patient.
Patent NZ-556603-A (NZ)
Title: A timing system and a method of timing for sports using antenna arrays and passive RFID tags
Inventor: EHLEN MATHIAS MARTIN ERNEST
IPC: G07C1/22
Filed: 2007-07-18
Abstract: A timing system (1) is disclosed. An array of antenna (4-9) radiate an activation field in an elongate timing region so that RFID transponders passing thought the region transmit identification signals that are used to generate timing information associated with competitors. A panel antenna (4-9) is preferably provided on the ground to create the elongate timing region and the system preferably operates at UHF. The RFID tag preferably uses a notch antenna and may be incorporated into a credit card. The timing system comprises a radio frequency signal source, a transmitting antenna array driven by the radio frequency signal source configured to illuminate an elongate timing region with portions of the array driven with modulated intensity. A receiving antenna (2, 3) receives signals generated by RFID transponders illuminated by the transmission antenna (4-9). These signals are sent to a timing circuit (10, 11) which generates timing information based on the signals. A computer (12) is used to store the timing information. Portions of the antenna array may be alternately driven, or modulated in other ways, to minimise standing waves and other discrepancies in the activation field.
Patent NZ-565918-A (NZ)
Title: Fixing group for facilitated attachment of a watercraft appliance onto a boat and method for attaching the same
Inventor: CAZZARO MICHELE
IPC: B66D1/28
Filed: 2008-02-13
Abstract: A fixing group of a watercraft appliance for the attachment thereof to an outer side of a deck wall of a boat comprises a base of the watercraft appliance and at least one seat formed in the base and suitable for receiving a respective threaded fastening element, so that said element has a free end projecting from the base for insertion into a respective through hole formed in the deck wall, so as to be accessible from the inner side of such a deck wall for fixing the watercraft appliance to it. The at least one seat comprises an access at a peripheral surface of the base and a retaining portion suitable for cooperating through shape coupling with said threaded fastening element to prevent the rotation and axial sliding thereof with respect to the base. The invention also refers to a method for attaching a watercraft appliance comprising said fixing group to a deck wall of a boat by means of threaded fastening elements.
Patent NZ-572520-A (NZ)
Title: Variable dose inhalation device using a resonant cavity to aerosolise a medicament for inhalation
Inventor: FLEMING SCOTT
IPC: A61M11/00
Filed: 2007-04-04
Abstract: An inhaler (10) to deliver a therapeutic agent or drug in selective doses from multiple dose packs is disclosed. The inhaler contains one or more vibrator mechanisms (36, 37) in one or more powder dispensing chambers (34, 35) for delivery of varying doses of a therapeutic agent or drug. Each pack contains 1 to 5 unit doses of the agent from which 1 to10 unit doses could be selectively delivered to a user.
Patent NZ-573793-A (NZ)
Title: Hiv reverse transcriptase inhibitors
Inventor: LEE ILL YOUNG
IPC: A61K31/513
Filed: 2007-07-24
Abstract: Disclosed is a pyrimidine compound of formula (I), (II) or (III) where the substituents are as disclosed in the description. An example of compounds of the invention are 3-[3-(5-Isopropyl-2,6-dioxo-1,2,3,6-tetrahydro-pyrimidine-4-carbonyl)-5-methyl-phenyl]-acrylonitrile. Also disclosed is the use of a compound of formula (I), (II) or (III) in the manufacture of a medicament for the treating or prevention of an HIV infection and a pharmaceutical composition comprising a compound of formula (I), (II) or (III).
Patent NZ-578827-A (NZ)
Title: New process for the synthesis of agomelatine
Inventor: BONTEMPELLI PASCAL
IPC: C07C231/06
Filed: 2009-08-03
Abstract: Disclosed is a process for the industrial synthesis of the compound of formula (I) characterised in that there is reacted (7-methoxy-1-naphthyl)acetonitrile of formula(II) which is subjected to reduction by hydrogen in the presence of Raney nickel in a medium comprising acetic anhydride in a polar protic medium to yield the compound of formula (I), which is isolated in the form of a solid.
Patent NZ-582670-A (NZ)
Title: Method for preparing FMOC-based hydrolysable linkers
Inventor: TURECEK PETER
IPC: C07D207/448
Filed: 2008-06-25
Abstract: Disclosed herein is a method of preparing a compound of formula 1, wherein PG is a protecting group and at least one of positions 1-8 is bound a N-maleimidyl-moiety having a structure as depicted by Y, wherein further substituents are as defined within the specification; said method comprises the step of reacting the 9-hydroxymethyl group of a compound as depicted by formula 2, wherein at least one of the positions 1-8 is bound to an amine, with a protecting group reagent introducing PG, and subsequently reacting said compound with an N-maleimidyl reagent to form the compound of formula (I).
Patent NZ-584381-A (NZ)
Title: Neutralizing human anti-IGFR antibody
Inventor: WANG YAN
IPC: C07K16/00
Filed: 2003-05-22
Abstract: Provided is a method for producing an IGFR antibody peptide with a specified amino acid sequence, comprising introducing the corresponding polynucleotide to Chinese hamster ovary (CHO) cells for cellular production. The expression vector can contain a CMV promoter, DHFR gene and hygromycin B gene with TK promoter.
Patent NZ-590465-A (NZ)
Title: Generation and use of high pressure air
Inventor: LLOYD ROBERT
IPC: F03D9/00
Filed: 2009-07-09
Abstract: 590465 A device for generating high pressure air. The device has a block with an external surface and an internal surface. The internal surface defines an internal cavity in the block. A rotor is located inside the cavity and rotates about under the influence of wind energy. The block is moves relative to the rotor in a direction orthogonal to the axis of rotation of the rotor so as to vary the position of the rotor within the cavity. A number of vanes extend from the rotor and are coupled to the rotor so that in every position that the block is capable of adopting relative to the rotor, the rotor is capable of rotating within the cavity while maintaining a seal between each vane and the internal surface of the block. There is a gas inlet channel and a gas outlet channel on an opposite side of the block to the gas inlet channel. The device also has a position controller for causing the block to move relative to the rotor so as to vary the position of the rotor within the cavity.
Patent NZ-592841-A (NZ)
Title: Machine for assembling cardboard tray, including clamping, folding, and ejecting means
Inventor: TOSEVSKI DIMITRI
IPC: B31B50/50
Filed: 2009-11-02
Abstract: A machine (100) to fold a cardboard blank into an open tray. The machine includes means to displace a blank (1a) from a stack of blanks (1) to a table (150), means (171) to clamp the blank in a fixed position to the table, folding means (180) to fold up sides and ends of the blank into vertically extending walls, consolidation means to urge overlapping flaps of the sides or ends into slots in the base of the blank, and means to eject the open tray from the machine.
Patent NZ-600980-A (NZ)
Title: Dental implant, abutment for a dental implant and combination thereof and an implant set
Inventor: SOLLBERGER DAVID
IPC: A61C8/00
Filed: 2011-01-13
Abstract: 600980 A dental implant (10) for inserting into a jaw bone and corresponding abutment (11) are disclosed. The receiving opening of the implant includes a conical section (17) with a cone angle of 6 to 20° which matches a corresponding cone section (117) of the abutment (110) The invention relates to an implant (10) serving to receive an abutment (110). Indexing sections (18, 118) include an at least partially cylindrical surface at least 90% of the length of the cone section (17, 117). The cylindrical surfaces act as a guide for guiding a protruding cam of the abutment (110) into engagement with a groove formed in the cylindrical section of the insert (10). The abutment (110) is suitable for receiving a tooth replacement or similar.
Patent NZ-603478-A (NZ)
Title: 2 -aminopyridine derivatives useful as inhibitors of atr kinase
Inventor: REAPER PHILIP MICHAEL
IPC: A61K31/4439
Filed: 2011-05-12
Abstract: The disclosure relates to 2-aminopyridine derivative compounds of formula (III) and pharmaceutically acceptable salts thereof, wherein the variables are as defined in the specification. These compounds are useful as inhibitors of ATR protein kinase and are suitable for treating cancer selected from lung cancer, head and neck cancer, pancreatic cancer, gastric cancer, and brain cancer.
Patent NZ-609297-A (NZ)
Title: Organic amine salts of aminobenzoic acid derivatives and method for producing same
Inventor: TAKEUCHI KAZUYA
IPC: A61P7/04
Filed: 2011-11-01
Abstract: Disclosed are salts of 3-{ [((2E)-2-{ 1-[5-(4-t-butylphenyl)-4-hydroxy-3-thienyl]ethylidene} hydrazino)carbonothioyl]amino} benzoic acid, wherein said salt is an organic amine salt or a salt with quaternary ammonium cation. Salts of particular importance include salts where the organic amine or quaternary ammonium salt is an organic amine or quaternary ammonium salt having a hydroxy group such as ethanolamine, tromethamine or choline. Further disclosed is a crystalline tromethamine salt of 3-{ [((2E)-2-{ 1-[5-(4-t-butylphenyl)-4-hydroxy-3-thienyl]ethylidene} hydrazino)carbonothioyl]amino} benzoic acid for use in medicine as a thrombopoietin receptor activator or a platelet increasing agent.
Patent NZ-610276-A (NZ)
Title: Tailoring a metal or modifying an electronic structure thereof
Inventor: NAGEL CHRISTOPHER J
IPC: C22C9/00
Filed: 2011-11-21
Abstract: A device for tailoring materials is disclosed. The device comprises a non-conductive support structure, a plurality of wire rings (1-5) of a conducting metal supported by said non-conductive support structure and at least one power source operably connected to each wire ring (1-5). The AC power is used to power at least one wire ring and DC power is used to power at least one wire ring (1-5).
Patent NZ-618571-A (NZ)
Title: Peptides and their use
Inventor: MERCER DERRY
IPC: C07K7/08
Filed: 2011-03-30
Abstract: Disclosed are peptides comprising RRRFRFFFRFRRR, HHHFRFFFRFRRR, KKFPWRLRLRYGRR, RRRRRFFFRFRRR, RRRFRFRFRFRRR, RRRFRFPFRFRRR, RRFRRFFFRRFRR, RRRRFFFRRRR, RRRRFRFRRRR, RRRRFPFRRRR, RRFRRRFRRFR, RRFRRRFRRFG, RRFGRRFRRFG, RRFRRFRRRFG, RRFRRFRRRFR, FRRRRFFFRFRRR, RRRRRFFFRRRRF, FFFFRRRRRFRRR, RRRRFFFFFRRRR, FRRRRFFFRRRRF, RRRYRYYYRYRRR, RRRARAAARARRR, RRRFRRRRRFFFF, RRRFFFFFFFRRR, further discloses the use of the peptide as an antimicrobial peptide on gram-positive and gram-negative bacteria.
Patent NZ-707016-A (NZ)
Title: Glycoprotein hormone long-acting superagonists
Inventor: SZKUDLINSKI MARIUSZ
IPC: C12N15/16
Filed: 2013-07-29
Abstract: This invention provides long-acting, superactive analogs of glycoprotein hormones demonstrating enhanced bioactivity both in vitro and in vivo as compared to wild type counterparts. The analogs are particularly useful for treating subjects showing low receptor expression or poor receptor responsiveness, and for the treatment of any condition associated with glycoprotein hormone activity.
Patent NZ-709276-A (NZ)
Title: Working platform system
Inventor: SHANE MICHAEL MORWOOD
IPC: E04G5/06
Filed: 2014-09-02
Abstract: A suspended, hook on scaffold system suitable for installing insulation on multi-storey buildings is described. The scaffolding can be attached to the upper levels of a building under construction, making large wrap around scaffolding built from the ground up unnecessary. The cantilever scaffold (12) abuts a vertical wall or support frame (F’) and hooks onto the floor where work is to be undertaken by a hook or catch or hitch or clamp (16), which includes a flange for mounting the hook portion to the floor by screwing or nailing. The scaffold can also include an telescopic or extendable rod or bracket (30) which can be attached to the frame by a brace (60) for added stability. Workers planks can be placed between multiple scaffolds to create a work platform.
Patent NZ-710720-A (NZ)
Title: Crenolanib for treating flt3 mutated proliferative disorders
Inventor: JAIN VINAY
IPC: A61P35/00
Filed: 2013-10-14
Abstract: The present invention relates to the use of crenolanib, in a pharmaceutically acceptable salt form for the treatment of FLT3 mutated proliferative disorders driven by constitutively activated mutant FLT3, and to a method of treatment of warm-blooded animals, preferably humans, in which a therapeutically effective dose of crenolanib is administered to an animal suffering from said disease or condition.
Patent NZ-726061-A (NZ)
Title: Agricultural baler with auxiliary power system
Inventor: VERHAEGHE DIDIER
IPC: A01F15/08
Filed: 2015-07-07
Abstract: Agricultural balers have become increasingly larger, resulting in the peak loads on the plunger during compression strokes become increasingly larger. One way to compensate for these higher peak loads is to use a larger flywheel coupled with a gearbox which drives the plunger, however a larger flywheel requires a larger traction unit. Described is an agricultural baler with an auxiliary power system which scavenges power from the driveline of the baler during off-peak load periods and transmits power back to the driveline for use during peak load periods.
Patent NZ-730121-A (NZ)
Title: Sheet material forming
Inventor: CASTELLUCCI MICHAEL
IPC: B44B5/00
Filed: 2015-09-07
Abstract: A method of forming a sheet metal material, the method comprising the steps of locating a sheet material between a pair of tools and moving the tools such that the tools form simultaneously a pattern of projections on both major surfaces of the sheet material by cold working on or in a first portion of the sheet metal material and indicia by embossing in a second portion of the sheet metal material at an interruption in the pattern of projections, wherein the form of the indicia is indicative of the alignment between the tools such that tool alignment and/or provenance can be monitored more simply and/or effectively.
Patent NZ-733844-A (NZ)
Title: Allele specific modulators of p23h rhodopsin
Inventor: FREIER SUSAN M
IPC: C12N15/113
Filed: 2016-02-26
Abstract: The present embodiments provide methods, compounds, and compositions for treating, preventing, ameliorating, or slowing progression of retinitis pigmentosa (RP), such as autosomal dominant retinitis pigmentosa (AdRP) by administering a P23H rhodopsin specific inhibitor to a subject. The present embodiments provided herein are directed to compounds and compositions useful for treating, preventing, ameliorating, or slowing progression of retinitis pigmentosa (RP), such as autosomal dominant retinitis pigmentosa (AdRP). The P23H rhodopsin inhibitors provided herein are allele-specific antisense modified oligonucleotides targeted to a P23H mutant allele that are capable of selectively inhibiting expression of P23H rhodopsin mutant protein to a greater extent than wild-type protein. In certain embodiments, administration of the allele specific antisense modified oligonucleotides in a subject having AdRP results in selective inhibition of P23H rhodopsin and allows the normal protein produced from the wild-type allele to maintain rod survival and function in the subject.